~ Oct 2010 Reverse Age-Related Weight Gain - References
References
1. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984;8(4):289-93.
2. Doi K, Nakamura T, Aoyama N, Matsurura M, Kawara A, Baba S. Metabolic and nutritional effects of long-term use of glucomannan in the treatment of obesity. In: Oomura Y, ed. Progress in Obesity Research. John Libbey & Company, Ltd., 1990:507-14.
3. Biancardi G, Palmiero L, Ghirardi PE. Glucomannan in the treatment of overweight patients with osteoarthritis. Curr Ther Res. 1989 Nov;46(5):908-12.
4. Di Pierro F, Borsetto Menghi AM, Barreca A, Lucarelli M, Calandrelli A. Highly bioavailable green tea: Clinical study on obese subjects. Integr Nutr. 2008;11(2):1-14.
5. Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med. 2007 Jul-Aug;13(4):32-7.
6. Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009 Mar 2;8:7.
7. Alonso-Sande M, Teijeiro-Osorio D, Remunan-Lopez C, Alonso MJ. Glucomannan, a promising polysaccharide for biopharmaceutical purposes. Eur J Pharmaceut Biopharmaceut. 2009;72:453-62.
8. U.S. Patent 3,856,945
9. U.S. Patent 3,928,322
10. U.S. Patent 3,973,008
11. U.S. Patent 3,767,424
12. Rodoriuez de Roa E, Marsicano Perez CLJ, Gomez N, Vargas E, Meneses PC. Pharmacologic intervention program in infantile obesity and dislipidemias: usefulness of the dietary fiber LuraLean™. Unpublished study.
13. Reffo GC, Ghiradi PE, Forattini C. Glucomannan in hypertensive outpatients: Pilot clinical trial. Curr Ther Res.1988 Jul;44(1): 22-7.
14. Vita PM, Restelli A, Caspani P, Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med. 1992 Mar;83(3):135-9.
15. Chua M, Baldwin TC, Hocking TJ, Chan K. Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br. J Ethnopharmacol. 2010 Mar 24;128(2):268-78.
16. Shimahara H, Suzuki H, Sugiyama N, Nisizawa K. Partial purification of—mannanases from the Konjac tubers and their substrate specificity in relation to the structure of Konjac glucomannan. Agr Biol Chem. 1975;39(2):301-12.
17. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev. 2004 Mar;9(1):63-9.
18. Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci. 2007 Jan 24;4(1):45-52.
19. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol. 2003 Dec;24(4):225-53.
20. Wang MY, Orci L, Ravazzola M, Unger RH. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci USA. 2005 Dec 13;102(50):18011-6.
21. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995 Jul 28;269(5223):543-6.
22. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996 Feb 1;334(5):292-5.
23. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 1996;104(4):293-300.
24. Omoruyi F, Adamson I. Digestive and hepatic enzymes in streptozotocin-induced diabetic rats fed supplements of dikanut (Irvingia gabonensis) and cellulose. Ann Nutr Metab. 1993; 37(1):14-23.
25. Oben JE, Ngondi JL, Blum K. Inhibition of Irvingia gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up-regulation of the adiponectin gene. Lipids Health Dis. 2008 Nov 13;7:44.
26. Westerterp-Plantenga MS. Green tea catechins, caffeine and body-weight regulation. Physiol Behav. 2010 Apr 26;100(1):42-6.
27. Rodondi N, Marques-Vidal P, Butler J, et al. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am J Epidemiol. 2010 Mar 1;171(5):540-9.
28. Puntmann VO, Taylor PC, Mayr M. Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: Systemic inflammation and aging - A mini-review. Gerontology. 2010 Jun 11.
1. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Effect of glucomannan on obese patients: a clinical study. Int J Obes. 1984;8(4):289-93.
2. Doi K, Nakamura T, Aoyama N, Matsurura M, Kawara A, Baba S. Metabolic and nutritional effects of long-term use of glucomannan in the treatment of obesity. In: Oomura Y, ed. Progress in Obesity Research. John Libbey & Company, Ltd., 1990:507-14.
3. Biancardi G, Palmiero L, Ghirardi PE. Glucomannan in the treatment of overweight patients with osteoarthritis. Curr Ther Res. 1989 Nov;46(5):908-12.
4. Di Pierro F, Borsetto Menghi AM, Barreca A, Lucarelli M, Calandrelli A. Highly bioavailable green tea: Clinical study on obese subjects. Integr Nutr. 2008;11(2):1-14.
5. Udani J, Singh BB. Blocking carbohydrate absorption and weight loss: a clinical trial using a proprietary fractionated white bean extract. Altern Ther Health Med. 2007 Jul-Aug;13(4):32-7.
6. Ngondi JL, Etoundi BC, Nyangono CB, Mbofung CM, Oben JE. IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans in a randomized double-blind placebo controlled investigation. Lipids Health Dis. 2009 Mar 2;8:7.
7. Alonso-Sande M, Teijeiro-Osorio D, Remunan-Lopez C, Alonso MJ. Glucomannan, a promising polysaccharide for biopharmaceutical purposes. Eur J Pharmaceut Biopharmaceut. 2009;72:453-62.
8. U.S. Patent 3,856,945
9. U.S. Patent 3,928,322
10. U.S. Patent 3,973,008
11. U.S. Patent 3,767,424
12. Rodoriuez de Roa E, Marsicano Perez CLJ, Gomez N, Vargas E, Meneses PC. Pharmacologic intervention program in infantile obesity and dislipidemias: usefulness of the dietary fiber LuraLean™. Unpublished study.
13. Reffo GC, Ghiradi PE, Forattini C. Glucomannan in hypertensive outpatients: Pilot clinical trial. Curr Ther Res.1988 Jul;44(1): 22-7.
14. Vita PM, Restelli A, Caspani P, Klinger R. Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med. 1992 Mar;83(3):135-9.
15. Chua M, Baldwin TC, Hocking TJ, Chan K. Traditional uses and potential health benefits of Amorphophallus konjac K. Koch ex N.E.Br. J Ethnopharmacol. 2010 Mar 24;128(2):268-78.
16. Shimahara H, Suzuki H, Sugiyama N, Nisizawa K. Partial purification of—mannanases from the Konjac tubers and their substrate specificity in relation to the structure of Konjac glucomannan. Agr Biol Chem. 1975;39(2):301-12.
17. Udani J, Hardy M, Madsen DC. Blocking carbohydrate absorption and weight loss: a clinical trial using Phase 2 brand proprietary fractionated white bean extract. Altern Med Rev. 2004 Mar;9(1):63-9.
18. Celleno L, Tolaini MV, D'Amore A, Perricone NV, Preuss HG. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. Int J Med Sci. 2007 Jan 24;4(1):45-52.
19. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol. 2003 Dec;24(4):225-53.
20. Wang MY, Orci L, Ravazzola M, Unger RH. Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci USA. 2005 Dec 13;102(50):18011-6.
21. Halaas JL, Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995 Jul 28;269(5223):543-6.
22. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996 Feb 1;334(5):292-5.
23. Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 1996;104(4):293-300.
24. Omoruyi F, Adamson I. Digestive and hepatic enzymes in streptozotocin-induced diabetic rats fed supplements of dikanut (Irvingia gabonensis) and cellulose. Ann Nutr Metab. 1993; 37(1):14-23.
25. Oben JE, Ngondi JL, Blum K. Inhibition of Irvingia gabonensis seed extract (OB131) on adipogenesis as mediated via down regulation of the PPARgamma and leptin genes and up-regulation of the adiponectin gene. Lipids Health Dis. 2008 Nov 13;7:44.
26. Westerterp-Plantenga MS. Green tea catechins, caffeine and body-weight regulation. Physiol Behav. 2010 Apr 26;100(1):42-6.
27. Rodondi N, Marques-Vidal P, Butler J, et al. Markers of atherosclerosis and inflammation for prediction of coronary heart disease in older adults. Am J Epidemiol. 2010 Mar 1;171(5):540-9.
28. Puntmann VO, Taylor PC, Mayr M. Coupling vascular and myocardial inflammatory injury into a common phenotype of cardiovascular dysfunction: Systemic inflammation and aging - A mini-review. Gerontology. 2010 Jun 11.
Free Shipping in the Continental U.S. on Orders over $50
The statements made here have not been evaluated by the FDA. The foregoing statements are based upon sound and reliable studies, and are meant for informational purposes. Consult with your medical practitioner to determine the underlying cause of your symptoms. Please always check your purchase for possible allergins and correct dosage on the bottle before use.
While we work to ensure that product information is correct, on occasion manufacturers may alter their ingredient lists. Actual product packaging and materials may contain more and/or different information than that shown on our Web site. We recommend that you do not solely rely on the information presented and that you always read labels, warnings, and directions before using or consuming a product. For additional information about a product, please contact the manufacturer. Content on this site is for reference purposes and is not intended to substitute for advice given by a physician, pharmacist, or other licensed health-care professional. You should not use this information as self-diagnosis or for treating a health problem or disease. Contact your health-care provider immediately if you suspect that you have a medical problem. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Life Ex Online assumes no liability for inaccuracies or misstatements about products.
- Life Extension - Life Extension Vitamins
- Metabolism-Garcinia HCA Life Extension
- Glucose Management
- Longevity & Wellness
- Antioxidants
- Body Care
- Bones
- Brain
- Chinese / Mushrooms
- Digestion
- Energy / Sports
- Health Concerns
- Heart / Circulation
- Hormone / Prostate
- Immune
- Inflammatory Factors
- Intimacy
- Liver / Urinary
- Phyto Extracts
- Powdered Supplements
- Seasonal / Respiratory
- Vitamins / Multivitamins / Aminos / Minerals
- Life Extension CoQ10
